ILLUMINATE-A, a phase 3 study of lumasiran, an investigational RNAi therapeutic, in children and adults with primary hyperoxaluria type 1 (PH1)

被引:0
作者
Garrelfs, Sander [1 ]
Frishberg, Yaacov [2 ]
Hulton, Sally [3 ]
Koren, Michael [4 ]
O'Riordan, William [5 ]
Cochat, Pierre [6 ,7 ,8 ]
Deschenes, Georges [9 ]
Shasha-Lavsky, Hadas [10 ]
Saland, Jeffrey [11 ]
van't Hoff, William [12 ]
Fuster, Daniel G. [13 ]
Magen, Daniella [14 ]
Moochhala, Shabbir [15 ]
Schalk, Gesa [16 ]
Simkova, Eva [17 ]
Groothoff, Jaap [1 ]
Sas, David [18 ]
Meliambro, Kristin [11 ]
Lu, Jiandong [19 ]
Garg, Pushkal [19 ]
Gansner, John [19 ]
McGregor, Tracy [19 ]
Lieske, John [18 ]
机构
[1] Amsterdam UMC, Dept Pediat Nephrol, Amsterdam, Netherlands
[2] Shaare Zedek Med Ctr, Div Pediat Nephrol, Jerusalem, Israel
[3] Birmingham Childrens Hosp, Dept Nephrol, Birmingham, W Midlands, England
[4] Jacksonville Ctr Clin Res, Jacksonville, FL USA
[5] EStudySite, San Diego, CA USA
[6] Hosp Civils Lyon, Lyon, France
[7] Univ Lyon, Ctr Rare Renal Dis, Lyon, France
[8] INSERM, Pediat Clin Invest Ctr, Lyon, France
[9] Hosp Robert Debre, Dept Pediat Nephrol, Paris, France
[10] Galilee Med Ctr, Nahariyya, Israel
[11] Icahn Sch Med, New York, NY USA
[12] Great Ormond St Hosp Sick Children, Dept Pediat Nephrol, London, England
[13] Univ Bern, Div Nephrol & Hypertens, Inselspital, Univ Hosp Bern, Bern, Switzerland
[14] Rambam Hlth Care Campus, Dept Pediat Nephrol, Haifa, Israel
[15] Royal Free Hosp, London, England
[16] Univ Bonn, Bonn, Germany
[17] Al Jalila Childrens Hosp, Dubai, U Arab Emirates
[18] Mayo Clin, Rochester, MN USA
[19] Alnylam Pharmaceut, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OC 15
引用
收藏
页码:8S / 8S
页数:1
相关论文
共 50 条
[41]   LUMASIRAN FOR PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1 WITH IMPAIRED KIDNEY FUNCTION: DATA FROM THE 6-MONTH ANALYSIS OF THE PHASE 3 ILLUMINATE-C TRIAL [J].
Groothoff, Jaap ;
Michael, Mini ;
Shasha-Lavsky, Hadas ;
Lieske, John ;
Frishberg, Yaacov ;
Simkova, Eva ;
Sellier-Leclerc, Anne-Laure ;
Arnaud, Devresse ;
Guebre-Egziabher, Fitsum ;
Bakkaloglu, Sevcan Azime ;
Mourani, Chebl ;
Saqan, Rola ;
Singer, Richard ;
Willey, Richard ;
Habtemariam, Bahru ;
Bhan, Ishir ;
Gansner, John ;
Magen, Daniella .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 :I837-I837
[42]   Deleterious AGXT Missense Variant Associated with Type 1 Primary Hyperoxaluria (PH1) in Zwartbles Sheep [J].
Letko, Anna ;
Dijkman, Reinie ;
Strugnell, Ben ;
Hafliger, Irene M. ;
Paris, Julia M. ;
Henderson, Katrina ;
Geraghty, Tim ;
Orr, Hannah ;
Scholes, Sandra ;
Drogemuller, Cord .
GENES, 2020, 11 (10) :1-9
[43]   DEVELOPMENT OF AN RNAI THERAPEUTIC TARGETING GLYCOLATE OXIDASE FOR THE TREATMENT OF PRIMARY HYPEROXALURIA TYPE 1 [J].
Liebow, Abigail ;
Erbe, David ;
Li, Xingsheng ;
Fargue, Sonia ;
Milstein, Stuart ;
Kuchimanchi, Satya ;
Fitzgerald, Kevin ;
Querbes, William ;
Holmes, Ross ;
Knight, John ;
Meyers, Rachel .
PEDIATRIC NEPHROLOGY, 2015, 30 (09) :1564-1564
[44]   Characteristics of a Brazilian cohort with primary hyperoxaluria type 1 (PH1), an admixed population with different ethnic origins [J].
Vaisbich, Maria ;
Naghettini, Alessandra ;
Melo, Ana Paula ;
Molin, Christine Zomer Dal ;
Sylvestre, Lucimary C. ;
Requiao, Lucio M. ;
Da Rocha, Pedro Tulio ;
Sobral, Roberta M. L. ;
Michelon, Tatiana ;
Cerqueira, Tiago L. ;
Vitorino, Vanessa ;
Heilberg, Ita Pfeferman .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
[45]   Primary Hyperoxaluria (PH): Type 1, 2, 3 or none? [J].
Menetrey, Anika ;
Stahr, Nicolai ;
Rothlisberger, Benno ;
Neuhaus, Thomas .
SWISS MEDICAL WEEKLY, 2018, 148 :23S-23S
[46]   PRIMARY HYPEROXALURIA (PH): TYPE 1, 2, 3 OR NONE? [J].
Menetrey, A. ;
Neuhaus, T. ;
Nikolai, S. ;
Rothlisberger, B. .
SWISS MEDICAL WEEKLY, 2018, 148 :65S-65S
[47]   Characteristics of a Brazilian cohort with primary hyperoxaluria type 1 (PH1), an admixed population with different ethnic origins [J].
Vaisbich, Maria ;
Naghettini, Alessandra ;
Melo, Ana Paula ;
Dal Molin, Christine Zomer ;
Sylvestre, Lucimary C. ;
Requiao, Lucio M. ;
Da Rocha, Pedro Tulio ;
Sobral, Roberta M. L. ;
Michelon, Tatiana ;
Cerqueira, Tiago L. ;
Vitorino, Vanessa ;
Heilberg, Ita Pfeferman .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 :I449-I450
[48]   Optimization of Hydroxyacidoxidase 1(HAO1) Targeting ARCUS Nucleases for the Treatment of Primary Hyperoxaluria Type 1 (PH1) [J].
Owens, Gary ;
Lewis, Whitney C. ;
Jordan-Steele, Matthew ;
Polak, Rachel ;
Lape, Janel ;
Smith, Jeff ;
Holt, Jason ;
Falls, Greg ;
Jantz, Derek .
MOLECULAR THERAPY, 2022, 30 (04) :116-116
[49]   COMBINED KIDNEY-LIVER TRANSPLANTATION OR KIDNEY TRANSPLANTATION ALONE FOR PRIMARY HYPEROXALURIA TYPE 1 (PH1): A FRENCH MULTICENTRIC STUDY [J].
Metzler, Philippe ;
Camus, Christophe ;
Rivalan, Joseph ;
Niaudet, Patrick ;
Samuel, Didier ;
Durrbach, Antoine ;
Bayle, Francois ;
Lang, Philippe ;
Merville, Pierre ;
Thervet, Eric ;
Bensman, Albert ;
Rostaing, Lionel ;
Deschenes, Georges ;
Boudjema, Karim ;
Compagnon, Philippe .
LIVER TRANSPLANTATION, 2009, 15 (07) :S95-S96
[50]   Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1 : Results from a Phase III Clinical Trial [J].
Saland, Jeffrey M. ;
Lieske, John C. ;
Groothoff, Jaap W. ;
Frishberg, Yaacov ;
Shasha-Lavsky, Hadas ;
Magen, Daniella ;
Moochhala, Shabbir H. ;
Simkova, Eva ;
Coenen, Martin ;
Hayes, Wesley ;
Hogan, Julien ;
Sellier-Leclerc, Anne-Laure ;
Willey, Richard ;
Gansner, John M. ;
Hulton, Sally -Anne .
KIDNEY INTERNATIONAL REPORTS, 2024, 9 (07) :2037-2046